IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Euclidean Capital LLC

Q1 2021 Holdings

Filed 2021-05-17 | 13 holdings | $22.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Alector Inc(ALEC)COM014442107$19.8M980,89487.7%
Beam Therapeutics Inc(BEAM)COM07373V105$2.5M31,13111.1%
PMV Pharmaceuticals Inc(PMVP)COM69353Y103$137.5K4,179,4160.6%
NGM Biopharmaceuticals Inc(NGMUSD)COM62921N105$43.4K1,493,3490.2%
Oric Pharmaceuticals Inc(ORIC)COM68622P109$24.4K996,7340.1%
Denali Therapeutics Inc(DNLI)COM24823R105$18.5K323,7490.1%
Foghorn Therapeutics Inc(FHTX)COM344174107$16.6K1,261,2610.1%
Rapt Therapeutics Inc(RAPTEUR)COM75382E109$16.3K735,8010.1%
Constellation Pharmceticls I(CNST)COM210373106$13.0K554,3250.1%
First Finl Bancorp OH(FFBC)COM320209109$4.2K173,5760.0%
VIR Biotechnology Inc(VIR)COM92764N102$1.3K25,8640.0%
Pinduoduo Inc(PDD)SPONSORED ADS722304102$1.1K8,1740.0%
Rubius Therapeutics IncCOM78116T103$33912,7910.0%